Key terms
About HROW
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest HROW news
Apr 11
8:52am ET
Craig-Hallum bullish on Harrow, initiates with a Buy
Apr 11
7:47am ET
Harrow initiated with a Buy at Craig-Hallum
Apr 03
5:04am ET
Analysts Offer Insights on Healthcare Companies: Lonza Group Ltd (Six Swiss: CH:LONN), Harrow Health (HROW) and Innoviva (INVA)
Mar 22
8:45am ET
Harrow price target lowered to $26 from $30 at B. Riley
Mar 21
12:45pm ET
Harrow Health’s Growth Trajectory: A Buy Rating Amid Strong Product Performance and Strategic Market Investments
Mar 21
9:09am ET
Lake Street sees ‘glass half full’ for Harrow, maintains Buy rating
Mar 20
8:55am ET
Lake Street Remains a Buy on Harrow Health (HROW)
Mar 20
8:32am ET
Harrow Health says CMS notification ‘very important development for IHEEZO’
Mar 20
8:30am ET
Harrow Health backs 2024 revenue guidance of at least $180M, consensus $184.91M
Mar 19
5:57pm ET
Harrow Health reports Q4 core EPS (20c), consensus (4c)
Mar 19
5:42pm ET
Harrow Health Inc Unveils Investor Presentation Update
Mar 19
8:06am ET
Options Volatility and Implied Earnings Moves Today, March 19, 2024
Feb 16
8:46am ET
Harrow Health (HROW) Gets a Buy from Lake Street
Feb 09
12:45pm ET
Harrow Health: A Strong Buy on Robust Product Growth and Strategic Initiatives
Jan 30
8:46am ET
Harrow Health (HROW) Gets a Buy from Lake Street
No recent press releases are available for HROW
HROW Financials
Key terms
Ad Feedback
HROW Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
HROW Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range